Getting the most from your curves: Exploring and reporting data using informative graphical techniques

Most psychological research employs tables to report descriptive and inferential statistics. Unfortunately, those tables often misrepresent critical information on the shape and variability of the datas distribution. In addition, certain information such as the modality and score probability density is hard to report succinctly in tables and, indeed, not reported typically in published research. This paper discusses the importance of using graphical techniques not only to explore data but also to report it effectively. In so doing, the role of exploratory data analysis in detecting Type I and Type II errors is considered. A small data set resembling a Type II error is simulated to demonstrate this procedure, using a conventional parametric test. A potential analysis routine to explore data is also presented. The paper proposes that essential summary statistics and information about the shape and variability of data should be reported via graphical techniques

Production of overdense plasmas by launching 2,45 GHz electron cyclotron waves in a helical device

For production of low temperature plasmas with low collisionality, 2.45GHz microwave power up to 20kW is injected perpendicularly to the toroidal field at very low toroidal field BtComment: 12th International Congress on Plasma Physics, 25-29 October 2004, Nice (France

Kinetic Analysis and Prediction of Thermal Decomposition Behavior of Tertiary Pyridine Resin in the Nitrate Form

AbstractThe thermal decomposition behavior of the tertiary pyridine resin, which was used during the nuclide-separation process in the Advanced Optimization by Recycling Instructive Elements (Advanced ORIENT) cycle, was investigated in its nitrate form (TPR-NO3), in order to determine ways of preventing its runaway reaction. A thermal analysis of TPR-NO3 and an analysis of the gases produced during decomposition were employed for the purpose. In addition, the kinetics parameters were evaluated via a kinetic analysis of the empirical thermal data. Finally, the validity of the reaction model was assessed by comparing the thermal behavior predicted by the estimated reaction model with that determined by the results of a gram-scale heating test performed in our previous study. We found that, when TPR-NO3 was heated, first, nitric acid was removed. Subsequently, TPR-NO3 was oxidized by the removed nitric acid. Under the assumption that it took place an autocatalytic oxidation and nth order thermal decomposition in parallel, the thermogravimetric analysis data could be fitted very well using a nonlinear regression model. The thermal behavior of TPR-NO3 could be predicted by the reaction model determined in this study under conditions where the cooling effect owing to evaporation was ignored. In addition, the maximum temperature and time to maximum rate of a runaway reaction predicted using the determined reaction model gave the result on the side of prudence

Experimental Simulation of High Temperature Plasma Transport Using Almost Dimensionally Similar Cold Plasmas in the Compact Helical System

In the Compact Helical System (CHS), experimental simulation of high temperature plasma transport is attempted by using cold plasma having similar dimensionless parameters such as electron-ion collision frequency normalized by bounce frequency v*ei, averaged toroidal beta value βt and the normalized gyro radius ρs*. The cold plasma is produced by 2.45 GHz electron cyclotron waves at very low toroidal field less than 0.1 T, and has v*ei ~ 0.05?1, βt < 0.02 % and ρs* ~ 0.02?0.05. The radial profiles of fluctuation amplitude have similarity to those in a high temperature plasma. In the cold plasma with low v*ei < 0.1, internal transport barrier is clearly formed in electron density and temperature profiles when the radial electric field rapidly evolves to positive value

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

<p>Abstract</p> <p>Background</p> <p>We recently examined the distribution of abdominal fat, dietary intake and biochemical data in patients with nonalcoholic fatty liver disease (NAFLD) and found that non-obese NAFLD patients did not necessarily exhibit insulin resistance and/or dysregulated secretion of adipocytokines. However, dietary cholesterol intake was superabundant in non-obese patients compared with obese patients, although total energy and carbohydrate intake was not excessive. Therefore, excess cholesterol intake appears to be one of the main factors associated with NAFLD development and liver injury.</p> <p>Methods</p> <p>We reviewed a year of follow-up data of non-obese NAFLD patients treated with Niemann-Pick C1 like 1 inhibitor ezetimibe to evaluate its therapeutic effect on clinical parameters related to NAFLD. Without any dietary or exercise modification, 10 mg/day of ezetimibe was given to 8 patients. In 4 of 8 patients, ezetimibe was administered initially. In the remaining 4 patients, medication was switched from ursodeoxycholic acid to ezetimibe.</p> <p>Results</p> <p>In each patient, body mass index was maintained under 25 kg/m²during the observation period. Serum ALT levels significantly decreased within 6 months and in 4 patients levels reached the normal range (<30 U/L), which was accompanied with at least a 10% decrease in serum total cholesterol and LDL-cholesterol. However, ultrasonographic findings of fatty liver did not show obvious improvement for a year.</p> <p>Conclusion</p> <p>We conclude that the cholesterol absorption inhibitor ezetimibe can suppress hepatic injury in non-obese patients with NAFLD and that ezetimibe may offer a novel treatment for NAFLD.</p

Prognostic Impact of Pre- and Post-operative P-CRP Levels in Pancreatic Cancer Patients

Background: C-reactive protein (CRP) levels reflect ongoing inflammation and/or tissue damage, and studies suggest that platelets play a role in tumor invasion and metastasis. P-CRP is defined as the multiplied product of serum CRP and platelet levels. Here the prognostic value of pre- and post-operative P-CRP levels in pancreatic cancer (PC) patients was assessed. Methods: This retrospective study used data from 107 consecutive PC patients who had undergone either pancreaticoduodenectomy or distal pancreatectomy. Clinicopathological parameters and pre/post-operative laboratory data derived from patient records were used for analyses. P-CRP was defined as the product of peripheral thrombocyte count (/uL) × serum CRP level (mg/dL) divided by 104; the optimal P-CRP cut-off value was defined using receiver operating characteristic curves. Results: PC patients were classified as either P-CRPLow (< 1.782; n = 49) or P-CRPHigh (≥ 1.782; n = 58), based on the cut-off value of 1.782. Univariate analysis revealed that performance status, clinical stage, pathological T and N stages, P-CRP, and carbohydrate antigen 19-9 (CA19-9) significantly affected overall survival (OS). Multivariate analysis revealed that independent risk factors for OS were pathological N stage, P-CRP, and CA19-9. Additionally, 103 PC patients for whom postoperative data were available were classified into four groups (P-CRPLow-Down, P-CRPLow-Up, P-CRPHigh-Down and P-CRPHigh-Up), based on preoperative P-CRP and postoperative trend of P-CRP, and we found that prognosis, in terms of OS, was significantly different among these groups (P = 0.012). Conclusion: Pre- and post-operative P-CRP values are a potential predictor of prognosis in PC patients

Impact of Energetic Ion Driven Global Modes on Toroidal Plasma Confinements

Excitation of energetic-ion-driven Alfv6n eigenmodes (AEs) and their impact on energetic ion confinement are widely and intensively studied in helical devices such as CHS and LHD as well as major tokamaks. The excitation of AEs sensitively depends on the parameter space defined by the averaged beam beta and the velocity ratio V6nlV6 (V611 : injected beam ion velocity, Va: Alfv6n velocity). In LHD, these two relevant parameters are widely scanned without suffering from current disruptions. So far, toroidicity induced AE (TAE), global AE (GAE) and energetic particle mode (EPM) or resonant TAE (R-TAE) were identified during tangential neutral beam injection (NBI) in CHS and LHD. Moreover, a new coherent mode with the frequency by about 8 times higher than the TAE frequency was observed in NBI heated plasmas of LHD at low magnetic field (<0.6T). This mode may be induced by helical field components of the confinement field. Nonlinear phenomena of bursting amplitude modulation and fast frequency chirping are clearly seen for TAEs and EPMs in CHS and LHD. EPMs in CHS and bursting TAEs in LHD enhance radial transport of energetic ions in certain plasma conditions

Tumour blood vessel normalisation by prolyl hydroxylase inhibitor repaired sensitivity to chemotherapy in a tumour mouse model

Blood vessels are important tissue structures that deliver oxygen and nutrition. In tumour tissue, abnormal blood vessels, which are hyperpermeable and immature, are often formed; these tissues also have irregular vascularisation and intravasation. This situation leads to hypoperfusion in tumour tissue along with low oxygen and nutrition depletion; this is also called the tumour microenvironment and is characterised by hypoxia, depleted nutrition, low pH and high interstitial pressure. This environment induces resistance to anticancer drugs, which causes an increase in anticancer drug doses, leading to increased side effects. We hypothesised that normalised tumour blood vessels would improve tumour tissue perfusion, resupply nutrition and re-oxygenate the tumour tissue. Chemotherapy would then be more effective and cause a decrease in anticancer drug doses. Here we report a neovascularisation-inducing drug that improved tumour vascular abnormalities, such as low blood flow, blood leakage and abnormal vessel structure. These results could lead to not only an increased chemo-sensitivity and tissue-drug distribution but also an up-regulated efficiency for cancer chemotherapy. This suggests that tumour blood vessel normalisation therapy accompanied by angiogenesis may be a novel strategy for cancer therapy